Two groups of individuals were patch tested for frequencies of contact allergy to dental materials. The patient group with orofacial and distant symptoms and complaints referred to the Department of Prosthetic Dentistry were compared with an age-sex matched control group of individuals referred to the Department of Dermatology. The results did not show any differences in patch test reactions between the patient and control groups. The study did not prove any obvious associations between the patients' symptoms or objective findings and the patch test results.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2842.1986.tb00650.xDOI Listing

Publication Analysis

Top Keywords

contact allergy
8
allergy dental
8
dental materials
8
referred department
8
patch test
8
materials patients
4
patients orofacial
4
orofacial complaints
4
complaints groups
4
groups individuals
4

Similar Publications

[Retrospective analysis in children with vaccination granuloma].

Dermatologie (Heidelb)

January 2025

Department of Dermatology and Allergy, Klinikum rechts der Isar, Technical University, München, Deutschland.

Background: Vaccine granulomas are a common (0.3-1%) adverse event (AE) of (accidentally) subcutaneously administered vaccines and specific immunotherapies containing aluminum conjugates. The clinical symptoms with persistent itching subcutaneous nodules, predominantly affect infants and young children on the lateral thigh.

View Article and Find Full Text PDF

Microbial species must compete for space and nutrients to persist in the gastrointestinal (GI) tract, and our understanding of the complex pathobiont-microbiota interactions is far from complete. Klebsiella pneumoniae, a problematic, often drug-resistant nosocomial pathogen, can colonize the GI tract asymptomatically, serving as an infection reservoir. To provide insight on how K.

View Article and Find Full Text PDF

Background: Doxepin (DX) is used orally to relieve itching but can cause side effects like blurred vision, dry mouth, and drowsiness due to its antimuscarinic effect. To reduce these adverse effects and improve skin permeation, DX is being developed in topical formulations. This study aims to improve DX skin absorption by developing a microemulsion (ME) formulation (ME-DX).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!